Usui Kimihito, Ohto Umeharu, Ochi Toshinari, Shimizu Toshiyuki, Satow Yoshinori
Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Tokyo 113-0033, Japan.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Jan 1;68(Pt 1):73-7. doi: 10.1107/S1744309111047920. Epub 2011 Dec 24.
β-D-Galactosidase (β-Gal) is an exoglycosidase that cleaves β-galactosides from glycoproteins, sphingolipids and keratan sulfate. This study reports the expression, purification, crystallization and preliminary X-ray crystallographic analysis of human lysosomal β-Gal. The sitting-drop vapour-diffusion method was used to crystallize β-Gal in complexes with its product galactose and with the inhibitor 1-deoxygalactonojirimycin. The resulting crystals were isomorphous and belonged to space group P2(1). The crystals of the β-Gal-galactose and the β-Gal-inhibitor complexes had unit-cell parameters a = 94.8, b = 116.1, c = 140.3 Å, β = 92.2° and a = 94.8, b = 116.0, c = 140.3 Å, β = 92.2°, respectively. Diffraction data were collected to 1.8 Å resolution for both crystals.
β-D-半乳糖苷酶(β-Gal)是一种外切糖苷酶,可从糖蛋白、鞘脂和硫酸角质素中裂解β-半乳糖苷。本研究报告了人溶酶体β-Gal的表达、纯化、结晶及初步的X射线晶体学分析。采用悬滴气相扩散法使β-Gal与其产物半乳糖以及抑制剂1-脱氧半乳糖野茉莉霉素形成复合物进行结晶。所得晶体为同晶型,属于空间群P2(1)。β-Gal-半乳糖复合物和β-Gal-抑制剂复合物的晶体的晶胞参数分别为a = 94.8、b = 116.1、c = 140.3 Å,β = 92.2°以及a = 94.8、b = 116.0、c = 140.3 Å,β = 92.2°。两种晶体均收集到了分辨率为1.8 Å的衍射数据。